IgG Placental Transfer in Healthy and Pathological Pregnancies

Carregando...
Imagem de Miniatura
Citações na Scopus
649
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI PUBLISHING CORPORATION
Autores
Citação
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, article ID 985646, 13p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Placental transfer of maternal IgG antibodies to the fetus is an important mechanism that provides protection to the infant while his/her humoral response is inefficient. IgG is the only antibody class that significantly crosses the human placenta. This crossing is mediated by FcRn expressed on syncytiotrophoblast cells. There is evidence that IgG transfer depends on the following: (i) maternal levels of total IgG and specific antibodies, (ii) gestational age, (iii) placental integrity, (iv) IgG subclass, and (v) nature of antigen, being more intense for thymus-dependent ones. These features represent the basis for maternal immunization strategies aimed at protecting newborns against neonatal and infantile infectious diseases. In some situations, such as mothers with primary immunodeficiencies, exogenous IgG acquired by intravenous immunoglobulin therapy crosses the placenta in similar patterns to endogenous immunoglobulins and may also protect the offspring from infections in early life. Inversely, harmful autoantibodies may cross the placenta and cause transitory autoimmune disease in the neonate.
Palavras-chave
Referências
  1. Abrams ML, 2011, ARCH DERMATOL, V147, P337, DOI 10.1001/archdermatol.2010.317
  2. Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394
  3. Akilesh S, 2004, J CLIN INVEST, V113, P1328, DOI 10.1172/JCI200418838
  4. Almeida VD, 2009, VACCINE, V27, P3856, DOI 10.1016/j.vaccine.2009.04.018
  5. ANEGON I, 1988, J EXP MED, V167, P452, DOI 10.1084/jem.167.2.452
  6. Antohe F, 2001, HUM IMMUNOL, V62, P93, DOI 10.1016/S0198-8859(00)00244-5
  7. Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0
  8. Baril L, 2004, CLIN EXP IMMUNOL, V135, P474, DOI 10.1111/j.1365-2249.2004.02357.x
  9. Beebe LA, 1996, OBSTET GYNECOL, V87, P771, DOI 10.1016/0029-7844(95)00483-1
  10. Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309
  11. BERGER M, 1982, JAMA-J AM MED ASSOC, V247, P2824, DOI 10.1001/jama.247.20.2824
  12. Berkowitz RL, 2007, OBSTET GYNECOL, V110, P249, DOI 10.1097/01.AOG.0000270302.80336.dd
  13. Bonhoeffer J, 2006, ARCH DIS CHILD, V91, P929, DOI 10.1136/adc.2005.086306
  14. BRAIR ME, 1994, LANCET, V343, P208, DOI 10.1016/S0140-6736(94)90991-1
  15. BRAMBELL FWR, 1960, P ROY SOC B-BIOL SCI, V151, P478, DOI 10.1098/rspb.1960.0011
  16. Branch DW, 2000, AM J OBSTET GYNECOL, V182, P122, DOI 10.1016/S0002-9378(00)70500-X
  17. BULMER JN, 1993, HISTOPATHOLOGY, V22, P219, DOI 10.1111/j.1365-2559.1993.tb00111.x
  18. Campo-Voegeli A, 2002, BRIT J DERMATOL, V147, P801, DOI 10.1046/j.1365-2133.2002.04969.x
  19. Casas R, 2001, PEDIATR ALLERGY IMMU, V12, P59, DOI 10.1034/j.1399-3038.2001.012002059.x
  20. CASSATELLA MA, 1989, J EXP MED, V169, P549, DOI 10.1084/jem.169.2.549
  21. COSTACARVALHO BT, 1988, REV LATINOAM PERINAT, V8, P98
  22. CostaCarvalho BT, 1996, BRAZ J MED BIOL RES, V29, P201
  23. Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845
  24. Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725
  25. de Moraes-Pinto MI, 1998, ARCH DIS CHILD, V79, pF202
  26. deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077
  27. DEMORAESPINTO MI, 1993, ACTA PAEDIATR, V82, P1034
  28. Doroudchi M, 2003, INT J GYNECOL OBSTET, V81, P157, DOI 10.1016/S0020-7292(02)00442-3
  29. Eibel H, 2010, CURR OPIN ALLERGY CL, V10, P526, DOI 10.1097/ACI.0b013e32833fea1c
  30. Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192
  31. Englund JA, 2007, J COMP PATHOL, V137, pS16, DOI 10.1016/j.jcpa.2007.04.006
  32. Englund JA, 1997, PEDIATR INFECT DIS J, V16, P1122, DOI 10.1097/00006454-199712000-00005
  33. ENGLUND JA, 1993, J INFECT DIS, V168, P647
  34. Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7
  35. ENGLUND JA, 1995, J INFECT DIS, V171, P99
  36. Escobar MC, 2007, CLIN RHEUMATOL, V26, P1161, DOI 10.1007/s10067-006-0282-6
  37. Farquhar C, 2005, JAIDS-J ACQ IMM DEF, V40, P494, DOI 10.1097/01.qai.0000168179.68781.95
  38. FERRANTE A, 1990, PEDIATR INFECT DIS J, V9, pS16
  39. Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993
  40. Firth Matthew A., 2005, Animal Health Research Reviews, V6, P143
  41. Fried M, 1998, J IMMUNOL, V160, P2523
  42. Friedman DM, 2008, CIRCULATION, V117, P485, DOI 10.1161/CIRCULATIONAHA.107.707661
  43. Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x
  44. GALL SA, 2011, AM J OBSTET GYNECOLO, V204
  45. Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346
  46. Gans H, 2003, VACCINE, V21, P3398, DOI 10.1016/S0264-410X(03)00341-4
  47. Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527
  48. Gardulf A, 2001, J CLIN IMMUNOL, V21, P150, DOI 10.1023/A:1011051704960
  49. Glezen WP, 2003, VACCINE, V21, P3389, DOI 10.1016/S0264-410X(03)00339-6
  50. GLEZEN WP, 1992, J INFECT DIS, V165, pS134
  51. Goncalves G, 1999, EPIDEMIOL INFECT, V122, P273, DOI 10.1017/S0950268899002046
  52. GRIFFIOEN AW, 1993, CLIN IMMUNOL IMMUNOP, V69, P1, DOI 10.1006/clin.1993.1142
  53. Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996
  54. Hansen RJ, 2002, THROMB HAEMOSTASIS, V88, P898
  55. Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010
  56. Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x
  57. Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
  58. Kaaja R, 2003, ARTHRITIS RHEUM, V48, P280, DOI 10.1002/art.10716
  59. KAMEDA T, 1991, PLACENTA, V12, P15, DOI 10.1016/0143-4004(91)90506-B
  60. Kane SV, 2009, AM J GASTROENTEROL, V104, P228, DOI 10.1038/ajg.2008.71
  61. Klouwenberg PK, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/628963
  62. Kobayashi R, 2009, AUTOIMMUN REV, V8, P462, DOI 10.1016/j.autrev.2008.12.013
  63. Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481
  64. Koyama M, 2000, AM J OBSTET GYNECOL, V183, P1537, DOI 10.1067/mob.2000.107789
  65. KRISTOFFERSEN BK, 1996, ACTA PATHOLOGICA M S, V104, P5
  66. LEACH L, 1990, CELL TISSUE RES, V261, P383, DOI 10.1007/BF00318681
  67. Lehmann D, 2003, VACCINE, V21, P3446, DOI 10.1016/S0264-410X(03)00348-7
  68. Lemke H, 2004, TRENDS IMMUNOL, V25, P180, DOI 10.1016/j.it.2004.02.007
  69. Lessa ALS, 2011, FEMS IMMUNOL MED MIC, V62, P236, DOI 10.1111/j.1574-695X.2011.00807.x
  70. Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075
  71. Li N, 2005, J CLIN INVEST, V115, P3440, DOI 10.1172/JCI24394
  72. Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
  73. MANTYJAR.R, 1970, IMMUNOLOGY, V18, P449
  74. Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012
  75. Marshall-Clarke S, 2000, IMMUNOL TODAY, V21, P35, DOI 10.1016/S0167-5699(99)01548-0
  76. MICHAUX JL, 1966, TROP GEOGR MED, V18, P10
  77. Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
  78. Mulholland K, 1996, JAMA-J AM MED ASSOC, V275, P1182, DOI 10.1001/jama.275.15.1182
  79. Munoz FM, 2001, VACCINE, V20, P826, DOI 10.1016/S0264-410X(01)00397-8
  80. Munoz FM, 2001, INFECT DIS CLIN N AM, V15, P253, DOI 10.1016/S0891-5520(05)70278-6
  81. Munoz FM, 2000, PEDIATR CLIN N AM, V47, P449, DOI 10.1016/S0031-3955(05)70217-0
  82. Nagao AT, 2001, SCAND J IMMUNOL, V53, P602, DOI 10.1046/j.1365-3083.2001.00921.x
  83. Nagao AT, 1999, J TROP PEDIATRICS, V45, P171, DOI 10.1093/tropej/45.3.171
  84. Nahm MH, 2003, VACCINE, V21, P3393, DOI 10.1016/S0264-410X(03)00340-2
  85. Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101
  86. Okoko BJ, 2002, ANN TROP PAEDIATR, V22, P325, DOI 10.1179/027249302125001985
  87. Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59
  88. OLATUNBOSUM OA, 1993, INT J GYNECOL OBSTET, V40, P162, DOI 10.1016/0020-7292(93)90379-B
  89. Palmeira P, 2009, PEDIATR ALLERGY IMMU, V20, P528, DOI 10.1111/j.1399-3038.2008.00828.x
  90. Palmeira P, 2007, EUR J PEDIATR, V166, P413, DOI 10.1007/s00431-006-0250-9
  91. Parlowsky T, 2003, J AM ACAD DERMATOL, V48, P623, DOI 10.1067/mjd.2003.170
  92. Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042
  93. PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189
  94. Quiambao BP, 2003, VACCINE, V21, P3451, DOI 10.1016/S0264-410X(03)00349-9
  95. Quiambao BP, 2007, VACCINE, V25, P4470, DOI 10.1016/j.vaccine.2007.03.021
  96. Radulescu L, 2004, HUM IMMUNOL, V65, P578, DOI 10.1016/j.humimm.2004.02.029
  97. Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
  98. Rose S, 2007, J IMMUNOL, V178, P2667
  99. Saint-Faust M, 2010, AM J PERINAT, V27, P107, DOI 10.1055/s-0029-1224873
  100. SAJI F, 1994, PLACENTA, V15, P453, DOI 10.1016/S0143-4004(05)80415-1
  101. Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081
  102. Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484
  103. Schelonka RL, 1998, SEMIN PERINATOL, V22, P2, DOI 10.1016/S0146-0005(98)80003-7
  104. Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963
  105. Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6
  106. Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508
  107. Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
  108. SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0
  109. SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718
  110. Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718
  111. Simister NE, 1998, VACCINE, V16, P1451, DOI 10.1016/S0264-410X(98)00107-8
  112. Stea EA, 2006, ARTHRITIS RHEUM, V54, P2228, DOI 10.1002/art.21954
  113. Tincani Angela, 2009, Curr Rheumatol Rep, V11, P70
  114. Tran HB, 2004, ARTHRITIS RHEUM, V50, P337, DOI 10.1002/art.11498
  115. van den Berg JP, 2010, PEDIATR INFECT DIS J, V29, P801, DOI 10.1097/INF.0b013e3181dc4f77
  116. Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2
  117. Vidarsson G, 1998, INFECT IMMUN, V66, P2866
  118. Vitoratos N., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P654
  119. Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200
  120. Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121
  121. Wesumperuma HL, 1999, ANN TROP MED PARASIT, V93, P169
  122. Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493
  123. Yeager DP, 1999, AM J PERINAT, V16, P283, DOI 10.1055/s-2007-993873
  124. Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311
  125. Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630